<DOC>
	<DOC>NCT00631319</DOC>
	<brief_summary>To evaluate the efficacy of OROS Hydromorphone in reducing moderate to severe chronic pain in patients with Osteoarthritis (OA) Pain</brief_summary>
	<brief_title>A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic OA Pain</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Hydromorphone</mesh_term>
	<criteria>Primary clinic diagnosis of OA pain of the hip or of the knee for at least 6 months Patients required daily opioid medication to treat their chronic OA pain Joint replacement of the hip or of the knee that is the primary source of OA Pain History drug or alcohol abuse Fibromyalgia Patients who plan to have joint replacement surgery within the next 6 months Patients who have major depression or anxiety Women who are pregnant or breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>OA</keyword>
	<keyword>Chronic Pain</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>OA Pain</keyword>
	<keyword>Osteoarthritis Pain</keyword>
	<keyword>Pain</keyword>
	<keyword>Hip Pain</keyword>
	<keyword>Knee Pain</keyword>
	<keyword>Joint Pain</keyword>
</DOC>